HomeSearch › Rosemarie Aloffredo - End 3312019

Rosemarie Aloffredo - End 3312019

CHIEF FIN OF at THE LEUKEMIA & LYMPHOMA SOCIETYINC · NY · Disease Research

$396K
Peak Total Compensation
2
Years Tracked
5x
vs. Median Household

Rosemarie Aloffredo - End 3312019 has appeared in compensation disclosures over 2 years of available data (2020–2021). Total compensation changed from $395,931 to $177,503 - a -55.2% change.

Peak total compensation of $395,931 equals 5x the median U.S. household income ($75,000).

Compensation History

Year-by-Year Detail

Year Organization Title Compensation Other Total
2021 THE LEUKEMIA & LYMPHOMA SOCIETYINC CHIEF FIN OF $177,503 - $177,503
2020 THE LEUKEMIA & LYMPHOMA SOCIETYINC CHIEF FIN OF $385,700 $10,231 $395,931

Peers at THE LEUKEMIA & LYMPHOMA SOCIETYINC

NameTitlePeak Comp.
Louis Jdegennaro-End 63023 PRESIDENT & CEO - FORMER $1.4M
Louis J Degennaro PRESIDENT & $1.1M
Gwen Nichols Md EVP, CHIEF MEDICAL OFC $654K
Troy Dunmire EVP, CHIEF OPERATING OFC $618K
Dale Nissenbaum EVP, GENERAL COUNSEL $544K
Gordon Miller Jr EVP, CHIEF FINANCIAL OFC $539K
Coker Powell SVP, CHIEF DEVELOPMENT OFC $506K
George J Omiros-Term Apr15 EVP-CHIEF CA $495K
E Anders Kolb - Start 512023 PRESIDENT & CEO $480K
Susan Brown SVP, CHIEF DEI OFC $471K
Email Alerts

Get notified about Rosemarie Aloffredo - End 3312019

Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.


Compare with another executive: Open comparison tool →